Calendar

Apr
15
Thu
Targeted Approaches to the Management of Moderate-to-Severe Asthma: Implications for Managed Care – An Innovative View
Apr 15 @ 6:30 pm – 7:30 pm

Targeted Approaches to the Management of Moderate-to-Severe Asthma: Implications for Managed Care – An Innovative View

FACULTY

Mario Castro, MD, MPH
Chief, Pulmonary, Critical Care and Sleep Medicine
Vice Chair for Clinical and Translational Research
Director, Frontiers: University Kansas Clinical & Translational Science Institute
Director, Rainbow Clinical Trials Science Unit
University of Kansas School of Medicine
Kansas City, KS

Geoffrey C. Wall, PharmD, FCCP, BCPS
Professor of Clinical Sciences
Drake University College of Pharmacy and Health Sciences
Internal Medicine Clinical Pharmacist
Iowa Methodist Medical Center
Consulting Partner
Medical Intelligence Group, PLLC
Des Moines, IA

EVENT DATE:
Thursday, April 15, 2021
6:30 PM – 7:30 PM ET

View Activity

Oct
18
Mon
Targeted Management of Asthma: Using Phenotypes and Biomarkers to Individualize Treatment
Oct 18 @ 6:30 am – 7:30 am

Targeted Management of Asthma:
Using Phenotypes and
Biomarkers to Individualize Treatment

This symposium is not supported, endorsed, or accredited by the American College of Chest Physicians.

Monday, October 18, 2021
6:30 AM – 7:30 AM CST

Please note this virtual program is 7:30AM Eastern, 6:30AM Central, 5:30AM Mountain and 4:30AM Pacific.

Program Features

  • Simulation animations
  • Interactive, case-based learning environment
  • Create your own Personalized Poster

Faculty

Nicola A Hanania, MD, MS, FCCP
Associate Professor of Medicine
Director, Airways Clinical Research Center Baylor College
of Medicine Director, Asthma and COPD Clinic
Ben Taub Hospital
Houston, TX

Diego J. Maselli, MD, FCCP
Associate Professor of Medicine
Division of Pulmonary Diseases & Critical Care
University of Texas Health Science Center at San Antonio
Director, Respiratory Care, University Health System
Director, Severe Asthma Program, University Health System
San Antonio, TX

Target Audience

This activity is intended for U.S.-based pulmonologists and other health care providers involved in the care of patients with moderate-to-severe asthma.

Learning Objectives

After completing the CME activity, learners should be better able to:

  • Utilize predictive biomarkers and clinical presentation to determine the phenotypes and endotypes of patients with asthma
  • Evaluate patients with severe asthma for symptom control and identify patients who require step-up therapy to minimize systemic steroid use and reduce emergency room visits
  • Develop individualized treatment plans for the management of moderate-to-severe asthma in pediatric and adult patients by incorporating updated guideline recommendations, clinical trial data, and patient-specific factors

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live virtual activity for a maximum of 1.0 AMA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live virtual activity.

CNE ACCREDITATION STATEMENT

Ultimate Medical Academy / Conference Complete Management (CCM) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission of Accreditation.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the management of patients with moderate-to-severe asthma.

CNE Credits: 1.0 ANCC Contact Hour

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at [email protected]

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the virtual event at [email protected]

Feel free to pass this invitation on to your physicians, fellows, physician assistants, nurses, pharmacists, healthcare practitioners, and any other colleagues that you believe would be interested in attending this free CME/CNE program.

REGISTER FOR LIVE VIRTUAL PROGRAM

Nov
7
Sun
Targeted Management of Asthma: Using Phenotypes and Biomarkers to Individualize Treatment
Nov 7 @ 6:00 pm – 7:30 pm

Moderate-to-Severe Asthma: Targeting Underlying Inflammatory Processes to Improve Patient Outcomes.

The Non-CME Corporate Forum content and views expressed therein do not necessarily reflect the views, policies or position of the American College of Allergy, Asthma & Immunology

Sunday, November 7, 2021
6:00 PM – 6:30 PM – Dinner/Registration
6:30 PM – 7:30 PM – Symposium

Hilton New Orleans Riverside Hotel
2 Poydras Street
New Orleans, LA 70130
Grand Ballroom Salon B (1st Floor)

Program Features

  • Simulation animation challenge
  • Interactive, case-based learning
  • Complimentary personalized online poster portal

Faculty

Diego J Maselli, MD
Associate Professor of Medicine
Division of Pulmonary Diseases & Critical Care
University of Texas Health Science Center at San Antonio
Director, Severe Asthma Program
University Health System
San Antonio, TX

Nicola A Hanania, MD
Associate Professor of Medicine
Section of Pulmonary and Critical Care Medicine
Director, Airways Clinical Research Center
Baylor College of Medicine
Houston, TX

Target Audience

This activity is designed to meet the needs of allergists, immunologists, and other health care providers involved in the care of patients with moderate-to-severe asthma.

Learning Objectives

After completing the activity, learners should be better able to:

  • Utilize knowledge of the type 2 inflammatory pathway to select therapies that target the underlying chronic inflammation associated with severe asthma and other commonly comorbid conditions
  • Assess disease severity and identify patients who require step-up therapy to manage symptoms, minimize systemic steroid use and reduce emergency room visits
  • Design evidence-based treatment plans for pediatric and adult patients with moderate-to-severe asthma that include patient-specific factors, such as comorbidities, quality of life, and treatment responses

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the virtual event at [email protected]

 

REGISTER FOR LIVE VIRTUAL PROGRAM